Skip to main content
Erschienen in: Digestive Diseases and Sciences 11/2021

12.01.2021 | Review

Chronic Viral Hepatitis Is Associated with Colorectal Neoplasia: A Systematic Review and Meta-Analysis

verfasst von: Seung Wook Hong, Won-Mook Choi, Ha Won Hwang, Dae Sung Kim, Jiyoung Yoon, Jin Wook Lee, Ju Hyun Shim, Dong-Hoon Yang, Seung-Jae Myung, Suk-Kyun Yang, Jeong-Sik Byeon

Erschienen in: Digestive Diseases and Sciences | Ausgabe 11/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Chronic viral hepatitis is associated with a wide range of extrahepatic diseases; however, evidence on a link between chronic viral hepatitis and colorectal neoplasia is still lacking.

Aims

To analyze the association between chronic viral hepatitis and prevalence of colorectal neoplasia.

Methods

A systematic review of articles published in the MEDLINE, EMBASE, and Cochrane Library between 2000 and 2020 was performed. Subgroup analyses based on the types of colorectal neoplasia and the etiology of chronic viral hepatitis were conducted.

Results

Twelve eligible studies with 48,428 hepatitis B virus (HBV) patients and 46,561 hepatitis C virus (HCV) patients were included. Chronic viral hepatitis was significantly associated with an increased risk of both colorectal adenoma (odds ratio [OR], 1.53; 95% confidence interval [CI], 1.16–2.02; I2 = 83%) and colorectal cancer (CRC) (OR, 1.32; 95% CI, 1.08–1.61; I2 = 94%). The etiology of chronic viral hepatitis was an independent factor related to heterogeneity for CRC subgroup analysis revealed an increased risk of CRC in both HBV (OR, 1.18; 95% CI, 1.09–1.27; I2 = 37%) and HCV (OR, 1.88; 95% CI, 1.78–1.97; I2 = 0%). HCV was associated with an increased risk of colorectal adenoma (OR, 1.48; 95% CI, 1.22–1.79; I2 = 0%); however, HBV was not associated with an increased risk of colorectal adenoma and had considerable heterogeneity (OR, 1.65; 95% CI, 0.88–3.09; I2 = 90%).

Conclusion

Our meta-analysis showed that chronic viral hepatitis is associated with an increased risk of colorectal neoplasia. The strategy of stricter screening colonoscopy may benefit from patients with chronic viral hepatitis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177–193.PubMedCrossRef Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177–193.PubMedCrossRef
2.
Zurück zum Zitat Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68:250–281.PubMedCrossRef Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68:250–281.PubMedCrossRef
3.
Zurück zum Zitat Løberg M, Kalager M, Holme Ø, et al. Long-term colorectal-cancer mortality after adenoma removal. N Engl J Med. 2014;371:799–807.PubMedCrossRef Løberg M, Kalager M, Holme Ø, et al. Long-term colorectal-cancer mortality after adenoma removal. N Engl J Med. 2014;371:799–807.PubMedCrossRef
4.
Zurück zum Zitat Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–696.PubMedPubMedCentralCrossRef Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–696.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Dwight MM, Kowdley KV, Russo JE, et al. Depression, fatigue, and functional disability in patients with chronic hepatitis C. J Psychosom Res. 2000;49:311–317.PubMedCrossRef Dwight MM, Kowdley KV, Russo JE, et al. Depression, fatigue, and functional disability in patients with chronic hepatitis C. J Psychosom Res. 2000;49:311–317.PubMedCrossRef
6.
Zurück zum Zitat El-Serag HB, Hampel H, Yeh C, et al. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology. 2002;36:1439–1445.PubMedCrossRef El-Serag HB, Hampel H, Yeh C, et al. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology. 2002;36:1439–1445.PubMedCrossRef
7.
Zurück zum Zitat Thuluvath PJ, John PR. Association between hepatitis C, diabetes mellitus, and race. a case-control study. Am J Gastroenterol. 2003;98:438–441.PubMed Thuluvath PJ, John PR. Association between hepatitis C, diabetes mellitus, and race. a case-control study. Am J Gastroenterol. 2003;98:438–441.PubMed
8.
Zurück zum Zitat Antonelli A, Ferri C, Pampana A, et al. Thyroid disorders in chronic hepatitis C. Am J Med. 2004;117:10–13.PubMedCrossRef Antonelli A, Ferri C, Pampana A, et al. Thyroid disorders in chronic hepatitis C. Am J Med. 2004;117:10–13.PubMedCrossRef
9.
Zurück zum Zitat Han SH. Extrahepatic manifestations of chronic hepatitis B. Clin Liver Dis. 2004;8:403–418.PubMedCrossRef Han SH. Extrahepatic manifestations of chronic hepatitis B. Clin Liver Dis. 2004;8:403–418.PubMedCrossRef
10.
Zurück zum Zitat Dan AA, Martin LM, Crone C, et al. Depression, anemia and health-related quality of life in chronic hepatitis C. J Hepatol. 2006;44:491–498.PubMedCrossRef Dan AA, Martin LM, Crone C, et al. Depression, anemia and health-related quality of life in chronic hepatitis C. J Hepatol. 2006;44:491–498.PubMedCrossRef
11.
Zurück zum Zitat Younossi Z, Park H, Henry L, et al. Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic Burden. Gastroenterology. 2016;150:1599–1608.PubMedCrossRef Younossi Z, Park H, Henry L, et al. Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic Burden. Gastroenterology. 2016;150:1599–1608.PubMedCrossRef
12.
Zurück zum Zitat Rustagi T, Zarookian EI, Qasba O, et al. Chronic hepatitis C as a risk factor for colorectal adenoma. Int J Colorect Dis. 2014;29:75–80.CrossRef Rustagi T, Zarookian EI, Qasba O, et al. Chronic hepatitis C as a risk factor for colorectal adenoma. Int J Colorect Dis. 2014;29:75–80.CrossRef
13.
Zurück zum Zitat Patel BB, Lipka S, Shen H, et al. Establishing the link between hepatitis B virus infection and colorectal adenoma. J Gastrointest Oncol. 2015;6:492–497.PubMedPubMedCentral Patel BB, Lipka S, Shen H, et al. Establishing the link between hepatitis B virus infection and colorectal adenoma. J Gastrointest Oncol. 2015;6:492–497.PubMedPubMedCentral
14.
Zurück zum Zitat Hurtado-Cordovi J, Davis-Yadley AH, Lipka S, et al. Association between chronic hepatitis C and hepatitis C/HIV co-infection and the development of colorectal adenomas. J Gastrointest Oncol. 2016;7:609–614.PubMedPubMedCentralCrossRef Hurtado-Cordovi J, Davis-Yadley AH, Lipka S, et al. Association between chronic hepatitis C and hepatitis C/HIV co-infection and the development of colorectal adenomas. J Gastrointest Oncol. 2016;7:609–614.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Kamiza AB, Su FH, Wang WC, et al. Chronic hepatitis infection is associated with extrahepatic cancer development: a nationwide population-based study in Taiwan. BMC Cancer 2016;16. Kamiza AB, Su FH, Wang WC, et al. Chronic hepatitis infection is associated with extrahepatic cancer development: a nationwide population-based study in Taiwan. BMC Cancer 2016;16.
16.
Zurück zum Zitat Allaire M, Nahon P, Layese R, et al. Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication. Hepatology. 2018;68:1245–1259.PubMedCrossRef Allaire M, Nahon P, Layese R, et al. Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication. Hepatology. 2018;68:1245–1259.PubMedCrossRef
17.
Zurück zum Zitat An J, Kim JW, Shim JH, et al. Chronic hepatitis B infection and nonhepatocellular cancers: a hospital registry-based, case-control study. PLoS ONE 2018;13. An J, Kim JW, Shim JH, et al. Chronic hepatitis B infection and nonhepatocellular cancers: a hospital registry-based, case-control study. PLoS ONE 2018;13.
18.
Zurück zum Zitat Kim SH, Kim JW, Lee KL, et al. Hepatitis B virus infection is independently associated with advanced colorectal adenoma. Am J Med Sci. 2018;356:141–146.PubMedCrossRef Kim SH, Kim JW, Lee KL, et al. Hepatitis B virus infection is independently associated with advanced colorectal adenoma. Am J Med Sci. 2018;356:141–146.PubMedCrossRef
19.
Zurück zum Zitat Kocoglu H, Karaca M, Tural D, et al. Hepatitis B and C rates are significantly increased in certain solid tumors: a large retrospective study. J Cancer Rese Ther. 2018;14:S774–S778.CrossRef Kocoglu H, Karaca M, Tural D, et al. Hepatitis B and C rates are significantly increased in certain solid tumors: a large retrospective study. J Cancer Rese Ther. 2018;14:S774–S778.CrossRef
20.
Zurück zum Zitat Jung YS, Kim NH, Park JH, et al. Correlation between hepatitis B virus infection and colorectal neoplasia. Jo Clin Med 2019;8. Jung YS, Kim NH, Park JH, et al. Correlation between hepatitis B virus infection and colorectal neoplasia. Jo Clin Med 2019;8.
21.
22.
Zurück zum Zitat Nyberg AH, Sadikova E, Cheetham C, et al. Increased cancer rates in patients with chronic hepatitis C. Liver Int. 2020;40:685–693.PubMedCrossRef Nyberg AH, Sadikova E, Cheetham C, et al. Increased cancer rates in patients with chronic hepatitis C. Liver Int. 2020;40:685–693.PubMedCrossRef
23.
Zurück zum Zitat Su FH, Le TN, Muo CH, et al. Chronic hepatitis B virus infection associated with increased colorectal cancer risk in Taiwanese population. Viruses. 2020;12:97.PubMedCentralCrossRef Su FH, Le TN, Muo CH, et al. Chronic hepatitis B virus infection associated with increased colorectal cancer risk in Taiwanese population. Viruses. 2020;12:97.PubMedCentralCrossRef
24.
Zurück zum Zitat Komaki Y, Komaki F, Micic D, et al. Risk of colorectal cancer in chronic liver diseases: a systematic review and meta-analysis. Gastrointest Endosc. 2017;86:93-104:e5.CrossRef Komaki Y, Komaki F, Micic D, et al. Risk of colorectal cancer in chronic liver diseases: a systematic review and meta-analysis. Gastrointest Endosc. 2017;86:93-104:e5.CrossRef
25.
Zurück zum Zitat Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283:2008–2012.CrossRefPubMed Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283:2008–2012.CrossRefPubMed
26.
Zurück zum Zitat Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647.CrossRefPubMed Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647.CrossRefPubMed
29.
Zurück zum Zitat Higgins JP, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions. New York: Wiley; 2019.CrossRef Higgins JP, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions. New York: Wiley; 2019.CrossRef
30.
Zurück zum Zitat Jung KW, Won YJ, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat. 2018;50:303–316.PubMedPubMedCentralCrossRef Jung KW, Won YJ, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat. 2018;50:303–316.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Leslie A, Carey FA, Pratt NR, et al. The colorectal adenoma-carcinoma sequence. Br J Surg. 2002;89:845–860.PubMedCrossRef Leslie A, Carey FA, Pratt NR, et al. The colorectal adenoma-carcinoma sequence. Br J Surg. 2002;89:845–860.PubMedCrossRef
32.
Zurück zum Zitat Kalaitzakis E, Gunnarsdottir SA, Josefsson A, et al. Increased risk for malignant neoplasms among patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9:168–174.PubMedCrossRef Kalaitzakis E, Gunnarsdottir SA, Josefsson A, et al. Increased risk for malignant neoplasms among patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9:168–174.PubMedCrossRef
33.
Zurück zum Zitat Hwang ST, Cho YK, Park JH, et al. Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps. J Gastroenterol Hepatol. 2010;25:562–567.PubMedCrossRef Hwang ST, Cho YK, Park JH, et al. Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps. J Gastroenterol Hepatol. 2010;25:562–567.PubMedCrossRef
34.
Zurück zum Zitat Lee YI, Lim YS, Park HS. Colorectal neoplasms in relation to non-alcoholic fatty liver disease in Korean women: a retrospective cohort study. J Gastroenterol Hepatol. 2012;27:91–95.PubMedCrossRef Lee YI, Lim YS, Park HS. Colorectal neoplasms in relation to non-alcoholic fatty liver disease in Korean women: a retrospective cohort study. J Gastroenterol Hepatol. 2012;27:91–95.PubMedCrossRef
35.
Zurück zum Zitat Shen H, Lipka S, Kumar A, et al. Association between nonalcoholic fatty liver disease and colorectal adenoma: a systemic review and meta-analysis. J Gastrointest Oncol. 2014;5:440–446.PubMedPubMedCentral Shen H, Lipka S, Kumar A, et al. Association between nonalcoholic fatty liver disease and colorectal adenoma: a systemic review and meta-analysis. J Gastrointest Oncol. 2014;5:440–446.PubMedPubMedCentral
36.
Zurück zum Zitat Virlogeux V, Trépo C. Extrahepatic manifestations of chronic hepatitis B infection. Curr Hepatol Rep. 2018;17:156–165.CrossRef Virlogeux V, Trépo C. Extrahepatic manifestations of chronic hepatitis B infection. Curr Hepatol Rep. 2018;17:156–165.CrossRef
37.
38.
Zurück zum Zitat Wu CG, Budhu A, Chen S, et al. Effect of hepatitis C virus core protein on the molecular profiling of human B lymphocytes. Mol Med. 2006;12:47–53.PubMedPubMedCentralCrossRef Wu CG, Budhu A, Chen S, et al. Effect of hepatitis C virus core protein on the molecular profiling of human B lymphocytes. Mol Med. 2006;12:47–53.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Kasprzak A, Adamek A. Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis. Hepatol Res. 2008;38:1–26.PubMedCrossRef Kasprzak A, Adamek A. Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis. Hepatol Res. 2008;38:1–26.PubMedCrossRef
40.
Zurück zum Zitat Hsieh A, Kim HS, Lim SO, et al. Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling. Cancer Lett. 2011;300:162–172.PubMedCrossRef Hsieh A, Kim HS, Lim SO, et al. Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling. Cancer Lett. 2011;300:162–172.PubMedCrossRef
41.
Zurück zum Zitat Cho KR, Vogelstein B. Genetic alterations in the adenoma–carcinoma sequence. Cancer. 1992;70:1727–1731.PubMedCrossRef Cho KR, Vogelstein B. Genetic alterations in the adenoma–carcinoma sequence. Cancer. 1992;70:1727–1731.PubMedCrossRef
43.
Zurück zum Zitat Mason A, Wick M, White H, et al. Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection. Hepatology. 1993;18:781–789.PubMedCrossRef Mason A, Wick M, White H, et al. Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection. Hepatology. 1993;18:781–789.PubMedCrossRef
44.
Zurück zum Zitat Fahal AH, el Razig SA, Suliman SH, et al. Gastrointestinal tract cancer in association with hepatitis and HIV infection. East Afr Med J. 1995;72:424–426.PubMed Fahal AH, el Razig SA, Suliman SH, et al. Gastrointestinal tract cancer in association with hepatitis and HIV infection. East Afr Med J. 1995;72:424–426.PubMed
45.
Zurück zum Zitat Russelli G, Pizzillo P, Iannolo G, et al. HCV replication in gastrointestinal mucosa: potential extra-hepatic viral reservoir and possible role in HCV infection recurrence after liver transplantation. PLoS ONE. 2017;12:e0181683.PubMedPubMedCentralCrossRef Russelli G, Pizzillo P, Iannolo G, et al. HCV replication in gastrointestinal mucosa: potential extra-hepatic viral reservoir and possible role in HCV infection recurrence after liver transplantation. PLoS ONE. 2017;12:e0181683.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Hetta HF, Mekky MA, Khalil NK, et al. Extra-hepatic infection of hepatitis C virus in the colon tissue and its relationship with hepatitis C virus pathogenesis. J Med Microbiol. 2016;65:703–712.PubMedPubMedCentralCrossRef Hetta HF, Mekky MA, Khalil NK, et al. Extra-hepatic infection of hepatitis C virus in the colon tissue and its relationship with hepatitis C virus pathogenesis. J Med Microbiol. 2016;65:703–712.PubMedPubMedCentralCrossRef
Metadaten
Titel
Chronic Viral Hepatitis Is Associated with Colorectal Neoplasia: A Systematic Review and Meta-Analysis
verfasst von
Seung Wook Hong
Won-Mook Choi
Ha Won Hwang
Dae Sung Kim
Jiyoung Yoon
Jin Wook Lee
Ju Hyun Shim
Dong-Hoon Yang
Seung-Jae Myung
Suk-Kyun Yang
Jeong-Sik Byeon
Publikationsdatum
12.01.2021
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 11/2021
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06745-x

Weitere Artikel der Ausgabe 11/2021

Digestive Diseases and Sciences 11/2021 Zur Ausgabe

DDS-SIRC Author Profile

Author Spotlight: Lisa Fralleone

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Chronisches Koronarsyndrom: Gefahr von Hospitalisierung wegen Herzinsuffizienz

06.05.2024 Herzinsuffizienz Nachrichten

Obwohl ein rezidivierender Herzinfarkt bei chronischem Koronarsyndrom wahrscheinlich die Hauptsorge sowohl der Patienten als auch der Ärzte ist, sind andere Ereignisse womöglich gefährlicher. Laut einer französischen Studie stellt eine Hospitalisation wegen Herzinsuffizienz eine größere Gefahr dar.

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

06.05.2024 Insomnie Nachrichten

Chronische Insomnie als eigenständiges Krankheitsbild ernst nehmen und adäquat nach dem aktuellen Forschungsstand behandeln: Das forderte der Schlafmediziner Dr. Dieter Kunz von der Berliner Charité beim Praxis Update.

GLP-1-Rezeptoragonisten und SGLT-2-Hemmer: zusammen besser

06.05.2024 Typ-2-Diabetes Nachrichten

Immer häufiger wird ein Typ-2-Diabetes sowohl mit einem GLP-1-Rezeptor-Agonisten als auch mit einem SGLT-2-Inhibitor behandelt. Wie sich das verglichen mit den Einzeltherapien auf kardiovaskuläre und renale Komplikationen auswirkt, wurde anhand von Praxisdaten aus Großbritannien untersucht.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.